Professional Documents
Culture Documents
Neuralgia
Neuralgia
, .., ..
TN vascular impingement.
abnormal nerve impulse trigeminal nerve pain excitability
threshold . vascular impingement
sensory axon. capacitance .
depolarization. sensory fiber
trigeminal nerve pain pathway ephaptic conduction
pain fiber . touch non-noxious receptor trigeminal nerve
pain pathway second order neuron spinal trigeminal nucleus synaptic convergence.
convergence trigeminal neuralgia
greater auricular nerve occipital nerve.
.
attack . idiopathic TN .
secondary symptomatic TN
. schawannoma trigeminal nerve reduced sensory
function weakness muscle of mastication . malnutrition
. trigger zone
. .
Onset
Duration
Characteristic
TG
With trigger
Seconds to minutes
Sharp, lancinating
Dental caries
TMJ disorder
Gradual
Gradual/ no trigger
Hours
Not paroxysmal
Throbbing
Exacerbated by jaw movement
.
(atypical manifestation of common disease VS typical manifestation of
rare disease).
headache, facial pain, neuralgia non-odontogenic cause .
1. Inadequate local dental cause of pain
2. Stimulating, burning, non-pulsatile pain
3. Constant, unremitting, non-variable pain
4. Persistent, recurrent pain over months or years
5. Spontaneous multiple episodes of toothache/pain
6. Failure to respond to local anesthetic block of any suspected tooth
7. Failure to respond to reasonable dental therapy of any suspected tooth
acute
sinusitis . muscle of mastication, trigeminal
sensory impairment long tract signs intracranial/intracerebral trigeminal
nerve . idiopathic TN .
TN exacerbation remission attack
remission .
idiopathic ( attack trigger zone ) vascular
impingement tumor compression progressive
.
vascular impingement tumor
. idiopathic TN
nerve block, nerve section, thermocoagulation gaserrian ganglion acupuncture .
idiopathic TN epileptic
seizure trigeminal nerve. analgesics paracetamol opiate compound .
antiepileptic drug
1. Carbamazepine therapeutic blood level 4-10
ugm/mL 600-1,200 mg/day. diplopia, headache,
agranulocytosis .
2. Phenytoin carbamazepine 300 mg/day
therapeutic blood level 10-2o ugm/mL. ataxia, gum hypertrophy,
hirsutisim, lymphadenopathy .
3. Valproate 600-1,200 mg/day, therapeutic blood level 50-100 ugm/mL.
alopecia, obesity, hepatic failure .
antidepressant antiepileptic drug
amitryptyline 10 mg/day. .
.
.
1. Lange DJ, Trojoborg W, Rowland LP. Peripheral and cranial nerve lesions. In: Rowland LP, ed. Merritt's
Textbook of Neurology. Baltimore: Williams & Wilkins, 1995, pp 461-484.
2. Nurmikko TJ, Eldridge PR. Trigeminal neuralgia--pathophysiology, diagnosis and current treatment. Br J
3.
4.
5.
6.
Anaesth. 2001;87:117-32
Okeson JP, Falace DA. Nonodontogenic toothache. Dent Clin North Am. 1997;41:367-83.
Sens MA, Higer HP. MRI of trigeminal neuralgia: initial clinical results in patients with vascular compression of
the trigeminal nerve. Neurosurg Rev. 1991;14:69-73.
Sindou MP, Chiha M, Mertens P. Anatomical findings observed during microsurgical approaches of the
cerebellopontine angle for vascular decompression in trigeminal neuralgia (350 cases). Stereotact Funct
Neurosurg. 1994;63:203-7.
Wilkins RH. Trigeminal Neuralgia. Introduction. IN: Wilkins RH, Rengachary SS, eds. Neurosurgery. New
York: McGraw-Hill, 1996, pp 3921-3929.
. , .., ..
2544.